Kolb
Andreas Kolb, Sulz CH
Patent application number | Description | Published |
---|---|---|
20090301213 | Pressure Gauge - A pressure gauge comprises a pressure gauge assembly and a connecting assembly. The pressure gauge assembly includes a measuring pressure port for the pressure to be measured and the connecting assembly includes a pressure measuring port. The pressure gauge assembly is adapted to be connected to the connecting assembly. In order to permit a relative rotation between the pressure gauge assembly and the connecting assembly, the pressure gauge assembly and/or the connecting assembly supports at least one annular passage section connecting the measuring pressure port to the pressure measuring port. | 12-10-2009 |
Andrew Kolb, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20150352549 | FLUIDIC CIRCUITS AND RELATED MANUFACTURING METHODS - Fluidic cartridges, and manufacture thereof, having a plurality of circuit element subtypes containing pneumatically operated diaphragm members, where the diaphragm materials are selected for yield point, chemical resistance, breathability and other properties individually according to the fluidic element subtype are provided. A process of in-situ edge-bonded decoupage for forming diaphragm members inside a cartridge, and fluidic circuits having diaphragm members as active and passive circuit elements, including pumps, valves, vents, waste receptacles, reagent reservoirs, and cuvettes with optical windows, where the material composition of each individual diaphragm member may be selected from an assortment of materials during manufacture are also provided. | 12-10-2015 |
Andrew W. Kolb, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20160109467 | MICROFLUIDIC DEVICES AND METHODS FOR PERFORMING SERUM SEPARATION AND BLOOD CROSS-MATCHING - Microfluidic cartridges or devices for serum separation and blood cross-match analysis are provided. The devices may include a serum separation subcircuit alone or in combination with a solute mixing subcircuit. The serum separation subcircuit promotes on-cartridge clotting of a blood sample and manipulates the flow of the separated serum sample for subsequent cross-match analysis with a second blood sample, for example. The solute mixing subcircuit includes at least two intake channels, one for a whole blood sample from, for example, a blood donor and the other for the separated serum sample from, for example, a transfusion recipient. The solute mixing subcircuit further includes a serpentine mixing channel conjoined to a downstream channel. Under vacuum generated by a conjoined finger pump, the two input streams fill the serpentine mixing and downstream channels due to capillary action, enabling visualization of an agglutination reaction. | 04-21-2016 |
Bryan Kolb, Lethbridge CA
Patent application number | Description | Published |
---|---|---|
20160022168 | BRAIN STATE DEPENDENT THERAPY FOR IMPROVED NEURAL TRAINING AND REHABILITATION - The disclosure provides an apparatus and method for assessing brain plasticity by measuring electrical brain biomarkers, for example, with a near real-time analysis of electrical brain biomarkers, where an increase or decrease in at least one biomarker is indicative of a state of brain plasticity in response to a stimulus or treatment. Brain plasticity can be measured with or without an added stimuli, for example, to determine the best time for learning. Also provided is a method for treating a neurological disease or trauma by applying an electrical or drug stimulus to a patient, where the stimulus is increased or decreased depending on the changes of electrical brain biomarker of the patient. This treatment can occur in near real-time, so a course of treatment can be tailored immediately to a patient's needs. | 01-28-2016 |
Ela Kolb, Jerusalem IL
Patent application number | Description | Published |
---|---|---|
20110065647 | NOVEL PEPTIDES ISOLATED FROM SPIDER VENOM, AND USES THEREOF - The presently described subject matter relates to isolated spider venom peptides, which are used as potent and selective ion channel blockers, and to a composition and methods for treatment of pain. | 03-17-2011 |
Jean-Pierre Kolb, Paris FR
Patent application number | Description | Published |
---|---|---|
20110263694 | Use of Xanthone Derivatives as a Medicament for Cancer - The invention relates to xanthone derivatives of formula (IA) or (IB) and their use for manufacturing a medicament for cancer, and in particular for chemotherapeutic resistant cancer. More particularly, the invention relates to compounds and compositions comprising such xanthone derivatives for the prevention and/or treatment for chronic leukemia and, for example, for chronic lymphocytic leukemia (CLL) or B-lymphoma. | 10-27-2011 |
Kelly Kolb, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20160055242 | SYSTEMS AND METHODS FOR ANALYZING CONTENT FROM DIGITAL CONTENT SOURCES - Methods and systems are provided for analyzing content items from digital content sources with respect to activity on communication networks. Content items are retrieved based on tracking set definitions from digital content sources via a network, and metadata is extracted from the retrieved content items. Communication related to the content items on one or more communication networks is periodically monitored, and the monitored communication is used to generate content scores for the retrieved content items based on one or more static content scores, dynamic content scores, and contextual relevance scores. The periodic monitoring allows trending information with respect to content items, authors, topics, and/or other data elements to be surfaced and analyzed. | 02-25-2016 |
Kenneth W. Kolb, Kajang MY
Patent application number | Description | Published |
---|---|---|
20080271729 | Insertable Thermotic Module for Self-Heating Can - A self-heating container having a container body with an internal beverage section and a thermic cavity. A liquid reactant is positioned in a first section of the thermic cavity and a solid reactant is positioned in a second section of the thermic cavity. The solid reactant may be an amount of CaO ranging from about 80 to 99 percent by weight combined with a wax based inhibitor ranging from about 1 to 20 percent by weight. The wax based inhibitor has a melting point ranging from above 100° C. to about 120° C. | 11-06-2008 |
Kenneth W. Kolb, Selangor MY
Patent application number | Description | Published |
---|---|---|
20100078010 | Insertable Thermotic Module for Self-Heating Can - A self-heating container having a container body with an internal beverage section and a thermic cavity. A liquid reactant is positioned in a first section of the thermic cavity and a solid reactant is positioned in a second section of the thermic cavity. The solid reactant may be an amount of CaO ranging from about 80 to 99 percent by weight combined with a wax based inhibitor ranging from about 1 to 20 percent by weight. The wax based inhibitor has a melting point ranging from above 100° C. to about 120° C. | 04-01-2010 |
Kurt Kolb, London GB
Patent application number | Description | Published |
---|---|---|
20150240300 | SENSING APPARATUS AND METHOD - Provided is a sensing apparatus comprising a chip for integrated amplification and sequencing of a template polynucleotide in a sample. The apparatus comprises a chip with at least one ISFET in a well or chamber, amplification means for amplifying the template polynucleotide on a surface of said chip and comprising at least one heating means suitable for conducting amplification of the template polynucleotide at temperatures elevated with respect to room temperature, and sequencing means for sequencing the amplified template polynucleotide in said well or chamber. Methods of use are also provided. | 08-27-2015 |
Kurt Robert Thor Kolb, Hillingdon GB
Patent application number | Description | Published |
---|---|---|
20090016744 | ABNORMAL USAGE DETECTION - A method and system compare actual consumable usage (e.g., toner usage) with expected consumable usage in a xerographic machine, such as a printer or copier. Expected toner usage may be predicted from pixel count (area coverage) and actual usage is obtained from monitoring of consumable usage, such as from toner dispense data or toner bottle replacements. If the actual toner usage differs significantly from the expected toner usage (e.g., ±40%), the system may take some action, such as scheduling of a service call. Early detection of abnormal consumable usage in a xerographic machine may allow early correction before any noticeable image defects occur, such as images that are too light or too dark. | 01-15-2009 |
20090016745 | REST RECOVERY SYSTEM, METHOD AND ALGORITHM - A method and computer program for preventing excess supply of toner in an imaging device include detecting a change in a tribo-electric charge of toner after a period of inactivity of the imaging device, compensating a toner dispense control value, such as a PID (Proportional, Integral, Differential) value, based on the detected change in the tribo-electric charge of toner, and outputting the compensated toner dispense control value. A system for preventing excess supply of toner includes a sensor that detects a change in a tribo-electric charge of toner after a period of inactivity of the imaging device, and a controller that compensates the toner dispense control value based on the detected change in the tribo-electric charge of toner and outputs the compensated toner dispense control value. The detected change may be based on a charge prior to the inactivity. | 01-15-2009 |
20090016754 | INTELLIGENT TONER CHARGING SYSTEM AND METHOD - A method and apparatus for charging toner for an imaging device includes an inactivity determining section that determines one or more periods of inactivity of the printing machine, a measuring section that measures a charge of the toner, and a charging section that charges the toner to a predetermined level based on at least one of the determined one or more periods of inactivity and the measured charge of the toner. The toner is charged to a predetermined level after recovery from the inactivity period so that the tribo-electric charge of the toner is enhanced for normal printing without causing unwanted effects when the imagining device recovers from inactivity. | 01-15-2009 |
Mark Kolb, Aurora CA
Patent application number | Description | Published |
---|---|---|
20100306055 | COMPELLED USER INTERACTION WITH ADVERTISEMENT WITH DYNAMICALLY GENERATED CHALLENGE - Software applications may include many types of sponsorship-related features, such as integrated advertisements displayed to users and captchas that improve advertisement targeting by distinguishing human users vs. automated processes. However, these techniques may consume developers' efforts and creativity, and, if not well-integrated in the application, may annoy or distract users. As an alternative technique, an advertisement may be programmatically analyzed to generate a challenge and a solution. The challenge and an input component may be integrated into the application; a user's challenge response may be automatically compared with the solution; and a reward may be presented for satisfactory input. This automated technique may better integrate advertisements with the application and may improve the effectiveness of the advertising, while also reducing the amount of developer effort and creativity expended on the advertisement integration. | 12-02-2010 |
Peter Kolb, Salzburg AT
Patent application number | Description | Published |
---|---|---|
20110077401 | ANTI-ANGIOGENIC COMPOUNDS - The invention relates to compounds of formula 1, tautomers and salts thereof, wherein R | 03-31-2011 |
Ranier Kolb, Kingwood, TX US
Patent application number | Description | Published |
---|---|---|
20160038929 | Regeneration of Aromatic Alkylation Catalyst Using Ozone - The present disclosure relates to a method of regenerating an at least partially deactivated catalyst, preferably an aromatic alkylation or transalkylation catalyst, comprising a molecular sieve. The method comprises the step of contacting the deactivated catalyst with an ozone-containing gas, preferably at a temperature of about 50° C. to about 250° C. | 02-11-2016 |